Zhejiang, China

Jinyu Zhang

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinyu Zhang. Retrieved from https://idiyas.com/inventor/jinyu-zhang-2bfl0caw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jinyu Zhang: Innovator in Nucleic Acid Technology

Introduction

Jinyu Zhang is a prominent inventor based in Zhejiang, China. She has made significant contributions to the field of nucleic acid technology, particularly in enhancing the stability and efficiency of mRNA.

Latest Patents

Jinyu Zhang holds a patent for a C6'-substituted locked nucleic acid-modified cap analog. This innovative cap analog improves the stability of mRNA and enhances its translation efficiency, showcasing her expertise in biochemistry and molecular biology. The patent is a testament to her commitment to advancing scientific knowledge and practical applications in the field.

Career Highlights

Jinyu Zhang is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. Her work at this esteemed pharmaceutical company allows her to apply her research in a practical setting, contributing to the development of new therapeutic solutions.

Collaborations

Jinyu collaborates with notable colleagues, including Kai Dong and Honglei Zhang. These partnerships enhance her research capabilities and foster innovation within her projects.

Conclusion

Jinyu Zhang is a remarkable inventor whose work in nucleic acid technology is paving the way for advancements in mRNA applications. Her contributions are vital to the ongoing evolution of pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…